MarketsandMarkets recently conducted a study on the “Apheresis Market -Applications(Plasmapheresis,Plateletpheresis,RBC/Erythrocytapheresis,Leukapheresis,Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables – Forecasts to 2017”, which analyzed and studied the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.
Browse 101 market data tables with 6 figures spread through 195 pages and in-depth TOC on “Apheresis Market – Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables – Forecasts to 2017”.
Early buyers will receive 10% customization on reports.
The apheresis process, which is based on various technologies, leverages platforms like automated devices, and disposables. It is a process wherein blood is collected and separated into different components, leveraging on centrifugation & membrane separation technology. The global apheresis market is valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017, growing at a CAGR of 11.0% from 2012 to 2017.
The apheresis market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market.
Developed markets account for a major share of the apheresis market, whereas emerging countries form the fastest growing markets. North America and Europe collectively contribute to more than 76.2% of the total apheresis market. Asian markets are expected to expand their share in the coming years due to increasing need of blood for transfusion & therapeutic apheresis due to a large population base in these countries.
The key growth strategies adopted by the companies have been studied between 2010 and 2012. Players in this market have adopted various strategies to expand their global footprint and increase market share. New product developments; agreements, partnerships and collaborations; mergers and acquisitions; and expansion are some of the major strategies adopted by players to achieve growth. Agreements, collaborations, joint ventures and partnerships accounted for 42% of the key growth strategies by key players such as Fresenius Medical Care AG (Germany), Cerus Corporation (U.S.), and Haemonetics Corporation (U.S.). For example, in April 2012, Cerus Corporation signed a supply agreement with King Faisal Specialist Hospital, a Saudi Arabia based blood service provider. The agreement allowed the hospital to use the INTERCEPT Blood System to treat its platelet production of around 5,600 units per year.
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports.
North – Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252